HIVEHIVE Digital Technologies Ltd.(HIVE)Stock Analysis

AI analysis on 2,800+ stocks →
FinancialsNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1720424HIVE stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

HIVE Stock Analysis & AI Quality Score

AI stock analysis and institutional research for HIVE Digital Technologies Ltd. (HIVE), a Financials sector company. HIVE is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q4 2026), HIVE Digital Technologies Ltd. reports quarterly revenue of $71.8M, net income of $-76.3M, free cash flow of $16.7M. Top institutional holders of HIVE by reported 13-F value include Invesco Ltd., MILLENNIUM MANAGEMENT, TWO SIGMA INVESTMENTS,, based on the most recent SEC filings. HIVE trades on the Nasdaq exchange and files with the SEC under CIK 1720424. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIVE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HIVE Digital Technologies Ltd. directly from SEC EDGAR.

Revenue

Q4 2026

$71.8M

Net Income

Q4 2026

$-76.3M

Free Cash Flow

Q4 2026

$16.7M

ROIC

Q4 2026

-14.4%

D/E Ratio

Q4 2026

0.00

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+160.2% YoY
$297.8MFY 2026
FY24 $114.5MFY26 $297.8M

Net Income

-660.2% YoY
$-148.4MFY 2026
FY24 $26.5MFY26 $-148.4M

EPS (Diluted)

-327.6% YoY
$-0.66FY 2026
FY24 $0.29FY26 $-0.66

Total Assets

+108.4% YoY
$639.1MFY 2026
FY24 $306.7MFY26 $639.1M

Total Debt

-63.7% YoY
$2.0MFY 2026
FY24 $5.6MFY26 $2.0M

Op. Cash Flow

+546.6% YoY
$62.3MFY 2026
FY24 $9.6MFY26 $62.3M

AI Insight: HIVE Financial Trends

Revenue growth stalled and profitability collapsed in Q1 2026 despite operational cash flow recovery.

Revenue declined 22% from Q4 2025 ($87M) to Q1 2026 ($72M), reversing prior three-quarter growth trajectory.

Net loss of $76M in Q1 2026 follows $16M loss in Q3 2025; cumulative two-quarter loss of $92M.

Operating cash flow improved to $17M in Q1 2026 from negative $11M in Q3 2025, signaling cash generation recovery.

Total debt reduced to $2M by Q1 2026 from $4M in Q1 2025; equity declined 18% from $625M peak (Q3 2025) to $529M.

Massive $76M net loss in Q1 2026 with zero reported operating income clarity—underlying profitability drivers opaque.

Equity eroded $96M from Q3 2025 to Q1 2026 despite low debt, indicating operating losses burning shareholder capital.

AI Insight: HIVE Ratio Trends

Profitability collapsed in Q1 2026 with net margin at -106.3%, erasing Q2 2025's strong 76.8% gains and signaling severe operational distress.

NPM swung from +76.8% in Q2 2025 to -18.1% in Q3 2025, then plummeted to -106.3% in Q1 2026—indicating persistent and worsening losses.

ROE and ROA both turned deeply negative in Q3 2025 (−10.1% and −9.1%) and deteriorated further in Q1 2026 (−57.7% and −47.8%).

Debt-to-equity ratio remained near zero (0.00–0.01) across all recent periods, preserving balance-sheet flexibility amid earnings collapse.

Q1 2026 marks fourth consecutive quarter of negative returns; investigate whether losses reflect temporary headwinds or structural business deterioration.

Sharp reversal from Q2 2025's exceptional profitability (NPM 76.8%, ROE 25.0%) suggests extreme seasonality, one-off charges, or material operational disruption.

Get alerted when HIVE's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HIVE Digital Technologies Ltd. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of HIVE

Put HIVE on your watchlist

Track score changes the day HIVE Digital Technologies Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HIVE a good stock to buy?

13F Pro's AI-powered analysis of HIVE Digital Technologies Ltd. (HIVE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HIVE are available on the HIVE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own HIVE?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HIVE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HIVE Digital Technologies Ltd.'s investment landscape.